Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Infarction | 21 | 2022 | 864 | 4.940 |
Why?
|
| Multiple Chronic Conditions | 6 | 2023 | 33 | 3.920 |
Why?
|
| Heart Failure | 12 | 2023 | 867 | 3.090 |
Why?
|
| Patient Readmission | 7 | 2021 | 420 | 1.630 |
Why?
|
| Hospitalization | 13 | 2022 | 1282 | 1.460 |
Why?
|
| Acute Coronary Syndrome | 4 | 2017 | 258 | 1.450 |
Why?
|
| Atrial Fibrillation | 9 | 2022 | 798 | 1.450 |
Why?
|
| Multimorbidity | 6 | 2023 | 38 | 1.310 |
Why?
|
| Chronic Disease | 5 | 2024 | 735 | 1.170 |
Why?
|
| Inpatients | 3 | 2019 | 296 | 1.020 |
Why?
|
| Aged | 33 | 2023 | 13339 | 1.020 |
Why?
|
| Survivors | 2 | 2017 | 148 | 1.020 |
Why?
|
| Diabetes Mellitus | 3 | 2022 | 537 | 0.960 |
Why?
|
| Angiotensin Receptor Antagonists | 4 | 2022 | 63 | 0.890 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 4 | 2022 | 142 | 0.870 |
Why?
|
| Hospital Mortality | 8 | 2018 | 846 | 0.820 |
Why?
|
| Hyperkalemia | 1 | 2022 | 23 | 0.810 |
Why?
|
| Male | 38 | 2023 | 27561 | 0.790 |
Why?
|
| Massachusetts | 16 | 2021 | 2086 | 0.790 |
Why?
|
| Retrospective Studies | 15 | 2023 | 6008 | 0.790 |
Why?
|
| Aged, 80 and over | 16 | 2023 | 5089 | 0.780 |
Why?
|
| Percutaneous Coronary Intervention | 4 | 2022 | 169 | 0.770 |
Why?
|
| Age Factors | 9 | 2021 | 1518 | 0.760 |
Why?
|
| Electrocardiography | 2 | 2015 | 524 | 0.750 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 131 | 0.720 |
Why?
|
| Risk Factors | 15 | 2022 | 5015 | 0.700 |
Why?
|
| Morbidity | 1 | 2020 | 109 | 0.700 |
Why?
|
| Mobility Limitation | 1 | 2020 | 49 | 0.700 |
Why?
|
| Female | 37 | 2023 | 30908 | 0.700 |
Why?
|
| Chest Pain | 2 | 2020 | 85 | 0.670 |
Why?
|
| Humans | 43 | 2024 | 59495 | 0.620 |
Why?
|
| Independent Living | 1 | 2018 | 45 | 0.610 |
Why?
|
| Anemia | 1 | 2019 | 117 | 0.600 |
Why?
|
| Risk Assessment | 7 | 2022 | 1914 | 0.600 |
Why?
|
| Disease Management | 1 | 2019 | 220 | 0.580 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2017 | 149 | 0.560 |
Why?
|
| Length of Stay | 7 | 2017 | 771 | 0.550 |
Why?
|
| Middle Aged | 19 | 2023 | 16275 | 0.550 |
Why?
|
| Time Factors | 10 | 2019 | 3579 | 0.530 |
Why?
|
| Psychosocial Deprivation | 1 | 2015 | 7 | 0.520 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 446 | 0.510 |
Why?
|
| Research | 1 | 2017 | 191 | 0.510 |
Why?
|
| Survival Rate | 5 | 2019 | 791 | 0.480 |
Why?
|
| Cardiac Catheterization | 2 | 2022 | 250 | 0.470 |
Why?
|
| Patient Discharge | 6 | 2017 | 479 | 0.460 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 2329 | 0.460 |
Why?
|
| Quality of Life | 6 | 2022 | 1116 | 0.450 |
Why?
|
| Myocardial Revascularization | 1 | 2014 | 71 | 0.440 |
Why?
|
| Diabetes Complications | 1 | 2014 | 102 | 0.430 |
Why?
|
| Secondary Prevention | 1 | 2014 | 153 | 0.420 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 421 | 0.420 |
Why?
|
| Forecasting | 1 | 2014 | 221 | 0.420 |
Why?
|
| Primary Prevention | 1 | 2014 | 137 | 0.410 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 212 | 0.390 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 252 | 0.390 |
Why?
|
| Comorbidity | 6 | 2020 | 1090 | 0.370 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 926 | 0.360 |
Why?
|
| Sex Factors | 6 | 2020 | 960 | 0.360 |
Why?
|
| Anxiety | 2 | 2020 | 395 | 0.350 |
Why?
|
| Treatment Outcome | 8 | 2017 | 5183 | 0.320 |
Why?
|
| Frailty | 2 | 2022 | 125 | 0.320 |
Why?
|
| Anxiety Disorders | 1 | 2011 | 188 | 0.320 |
Why?
|
| Chi-Square Distribution | 4 | 2017 | 403 | 0.310 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 827 | 0.310 |
Why?
|
| Stroke | 4 | 2022 | 1138 | 0.310 |
Why?
|
| Cause of Death | 2 | 2019 | 200 | 0.300 |
Why?
|
| Depressive Disorder, Major | 1 | 2011 | 258 | 0.290 |
Why?
|
| Depression | 2 | 2020 | 857 | 0.260 |
Why?
|
| United States | 4 | 2020 | 7511 | 0.260 |
Why?
|
| Coronary Artery Bypass | 3 | 2022 | 274 | 0.250 |
Why?
|
| Prognosis | 5 | 2017 | 1572 | 0.240 |
Why?
|
| Cohort Studies | 5 | 2018 | 2442 | 0.220 |
Why?
|
| Prevalence | 2 | 2019 | 1281 | 0.220 |
Why?
|
| Potassium | 1 | 2022 | 109 | 0.200 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2021 | 13 | 0.190 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 265 | 0.180 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 254 | 0.180 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 53 | 0.180 |
Why?
|
| Anticoagulants | 2 | 2022 | 487 | 0.180 |
Why?
|
| Needs Assessment | 1 | 2021 | 188 | 0.170 |
Why?
|
| Frail Elderly | 1 | 2020 | 110 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2022 | 314 | 0.170 |
Why?
|
| Adult | 6 | 2024 | 15783 | 0.170 |
Why?
|
| Hemorrhage | 1 | 2021 | 277 | 0.160 |
Why?
|
| Musculoskeletal Diseases | 1 | 2020 | 101 | 0.160 |
Why?
|
| Adaptation, Psychological | 2 | 2012 | 262 | 0.160 |
Why?
|
| Osteoarthritis | 1 | 2020 | 129 | 0.150 |
Why?
|
| Prospective Studies | 4 | 2022 | 3101 | 0.150 |
Why?
|
| Incidence | 3 | 2018 | 1237 | 0.150 |
Why?
|
| Logistic Models | 3 | 2016 | 1252 | 0.150 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 233 | 0.140 |
Why?
|
| Drug Interactions | 1 | 2017 | 115 | 0.140 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 2592 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 114 | 0.130 |
Why?
|
| Patient Care Management | 1 | 2016 | 29 | 0.130 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 55 | 0.130 |
Why?
|
| Lung Diseases | 1 | 2017 | 164 | 0.130 |
Why?
|
| Georgia | 1 | 2015 | 88 | 0.130 |
Why?
|
| Health Services Research | 1 | 2017 | 270 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 115 | 0.130 |
Why?
|
| Hypolipidemic Agents | 1 | 2015 | 34 | 0.130 |
Why?
|
| Diuretics | 1 | 2015 | 58 | 0.130 |
Why?
|
| Calcium Channel Blockers | 1 | 2015 | 56 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2018 | 352 | 0.120 |
Why?
|
| Self Report | 3 | 2022 | 366 | 0.120 |
Why?
|
| Caregivers | 1 | 2017 | 216 | 0.120 |
Why?
|
| Health Status | 1 | 2017 | 449 | 0.120 |
Why?
|
| Aging | 1 | 2020 | 723 | 0.110 |
Why?
|
| Stroke Volume | 1 | 2015 | 318 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1225 | 0.110 |
Why?
|
| Personality Inventory | 2 | 2011 | 50 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 314 | 0.100 |
Why?
|
| Aspirin | 1 | 2014 | 186 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1031 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2012 | 92 | 0.100 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 220 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1063 | 0.090 |
Why?
|
| Angina, Unstable | 1 | 2011 | 58 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 384 | 0.090 |
Why?
|
| Pediatrics | 1 | 2013 | 266 | 0.090 |
Why?
|
| Fear | 1 | 2011 | 64 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2014 | 886 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1449 | 0.080 |
Why?
|
| Mental Health Services | 1 | 2013 | 299 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 542 | 0.080 |
Why?
|
| Sex Distribution | 2 | 2018 | 254 | 0.070 |
Why?
|
| Age Distribution | 2 | 2018 | 261 | 0.070 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 161 | 0.070 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2024 | 48 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2468 | 0.060 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2002 | 10 | 0.050 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2002 | 20 | 0.050 |
Why?
|
| Fluoxetine | 1 | 2002 | 44 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2015 | 773 | 0.050 |
Why?
|
| Acute Disease | 2 | 2015 | 659 | 0.050 |
Why?
|
| Perception | 1 | 2022 | 179 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2002 | 229 | 0.050 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2021 | 119 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2002 | 293 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 298 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 459 | 0.040 |
Why?
|
| Social Support | 1 | 2020 | 358 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 248 | 0.040 |
Why?
|
| Urban Health | 1 | 2015 | 43 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 48 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 916 | 0.030 |
Why?
|
| Shock, Cardiogenic | 1 | 2015 | 85 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 256 | 0.030 |
Why?
|
| Checklist | 1 | 2013 | 75 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2013 | 576 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 553 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 673 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2013 | 296 | 0.020 |
Why?
|
| Edema | 1 | 2010 | 40 | 0.020 |
Why?
|
| Dyspnea | 1 | 2010 | 108 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2010 | 279 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 703 | 0.020 |
Why?
|
| Cough | 1 | 2010 | 182 | 0.020 |
Why?
|
| Adolescent | 2 | 2013 | 5930 | 0.020 |
Why?
|
| Mass Screening | 1 | 2013 | 647 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2010 | 715 | 0.010 |
Why?
|
| Child | 1 | 2013 | 4304 | 0.010 |
Why?
|
| Postmenopause | 1 | 2002 | 246 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2002 | 680 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 809 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 668 | 0.010 |
Why?
|